| Registered Number:11554768 |
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
For the year ended 30 September 2024
Five Pharm Ltd
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
Five Pharm Ltd
Statement of Financial Position
2023
2024
| Property, plant and equipment |
673,960
658,798
2
673,960
658,798
25,000
30,000
3
| Trade and other receivables |
20,427
37,780
4
346,929
| Cash and cash equivalents |
359,347
427,127
392,356
| Trade and other payables: amounts falling due within one |
| year |
(440,111)
(293,353)
5
(47,755)
133,774
Net current assets
| Total assets less current liabilities |
807,734
611,043
807,734
Net assets
611,043
2
1
807,732
611,042
807,734
611,043
Shareholders' funds
| For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006 |
| The director acknowledges his responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each |
| financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and |
| which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as |
| applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| These financial statements were approved and authorised for issue by the Board on 26 November 2024 and were signed by: |
| The notes form part of these financial statements |
1 of 3
For the year ended 30 September 2024
Five Pharm Ltd
Notes to the Financial Statements
Statutory Information
| Five Pharm Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 11554768. |
7 Priestwood Square
Windlesham Road
Bracknell
England
RG24 1UD
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting Standard |
| 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006. The |
| financial statements have been prepared under the historical costs convention as modified by the revaluation of certain assets. |
Revenue recognition
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax or other similar sales taxes. |
Property, plant and equipment
| Property, plant and equipment, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis: |
Computer Equipment
Motor Vehicles
Furniture and Fittings
Investment property
| Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss. |
Inventories
| Inventories are value at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
Deferred tax
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straightline basis over the period of the lease.
Pension costs and other post-retirement benefits
| The company operates a defined contribution pension scheme for the benefit of its directors/and employees. Contributions payable are charged to the profit and loss account in the period in which they are payable. |
2 of 3
For the year ended 30 September 2024
Five Pharm Ltd
Notes to the Financial Statements Continued
| 2. Property, plant and equipment |
670,000
15,000
45,000
-
610,000
24,980
-
-
24,980
-
24,980
45,000
15,000
694,980
610,000
| Provision for depreciation and impairment |
11,202
3,167
8,035
-
-
Charge for year
9,818
1,775
5,545
2,498
-
21,020
4,942
13,580
2,498
-
610,000
22,482
31,420
10,058
673,960
610,000
-
36,965
11,833
658,798
2023
2024
30,000
25,000
| 4. Trade and other receivables |
2023
2024
37,780
20,427
| 5. Trade and other payables: amounts falling due within one year |
2023
2024
| Bank loans and overdraft (secured) |
132,414
164,421
54,649
76,649
| Taxation and social security |
76,290
65,133
30,000
133,908
293,353
440,111
| 6. Average number of persons employed |
During the year the average number of employees was 0 (2023 : 7)
3 of 3